APAC Urinary Catheter Industry to 2031

0

DUBLIN, February 2, 2022 /PRNewswire/ — The “Urinary Catheters Market – Asia-Pacific Industry Analysis, Size, Share, Growth, Trends and Forecast, 2021-2031” report has been added to from ResearchAndMarkets.com offer.

This report on Urinary Catheters Market in Asia Pacific studies the past and current growth trends and opportunities to gain valuable insights into the market indicators during the forecast period from 2021 to 2031. The report provides the global Urinary Catheters market revenue in Asia Pacific for the period 2017-2031, considering 2020 as the reference year and 2031 as the forecast year. The report also provides the Compound Annual Growth Rate (CAGR) of the Urinary Catheters market in Asia Pacific for the forecast period.

The report has been prepared after extensive research. Primary research involved the bulk of research efforts, in which analysts conducted interviews with industry leaders and opinion makers. Secondary research consisted of referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Urinary Catheters market in Asia Pacific.

Secondary research also included internet sources, statistical data from government agencies, websites and professional associations. Analysts have also used a combination of top-down and bottom-up approaches to study various phenomena in the Urinary Catheters market in Asia Pacific.

The report includes an elaborate executive summary, along with an overview of the growth behavior of the various segments and sub-segments included in the scope of the study. Further, the report sheds light on changing competitive dynamics in the Urinary Catheters market in Asia Pacific. These indexes are invaluable tools for existing market players as well as entities interested in participating in the Urinary Catheters market in Asia Pacific. The following section of the Urinary Catheters Market report highlights USPs, which include impact of COVID-19 pandemic on industry (value chain and short/medium/long term impact), advancements technologies, key industry events and the prevalence of urinary incontinence across Asia Pacific.

The report dives into the competitive landscape of the Urinary Catheters market in Asia Pacific. Key Players Operating in the Urinary Catheters Market Asia Pacific were identified, and each of them was profiled to distinguish business attributes. Company overview, financial status, recent developments and SWOT are some of the attributes of players presented in the Urinary Catheters market in the report.

Key questions answered in the Asia-Pacific Urinary Catheters market report

  • What are the sales/revenues generated by urinary catheters across Asia Pacific during the forecast period?
  • What are the key trends in the Urinary Catheters market in Asia Pacific?
  • What are the major market drivers, restraints, opportunities and threats?
  • Which segment will have the highest revenue by 2031 and which segment will experience the highest CAGR during the forecast period?

Main topics covered:

1. Preface

2. Assumptions and research methodology

3. Executive Summary: Asia-Pacific Urinary Catheters Market

4. Market Overview
4.1. introduction
4.1.1. Market definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market dynamics
4.3.1. Drivers
4.3.2. Constraints
4.3.3. Opportunities
4.4. Asia-Pacific Urinary Catheters Market Analysis and Forecast, 2018-2031
4.4.1. Market revenue projections (millions of US dollars)

5. Key information
5.1. Technological advances
5.2. Key industry events
5.3. Prevalence of urinary incontinence in the region
5.4. Impact of COVID-19 Pandemic on Asia-Pacific Urinary Catheters Market

6. Asia Pacific Urinary Catheters Market Analysis and Forecast, by Type
6.1. Presentation and definition
6.2. Main results/developments
6.3. Forecast Asia-Pacific Urinary Catheters Market Value (USD Million), by Type, 2017-2031
6.3.1. Intermittent autocatheters (ISC)
6.3.1.1. Covered
6.3.1.2. Uncoated
6.3.1.3. Pre-lubricated
6.3.2. Foley catheters
6.3.3. Others
6.4. Asia-Pacific Urinary Catheters Market Attractiveness Analysis, By Type

7. Asia-Pacific Urinary Catheters Market Analysis and Forecast, by Distribution Channel
7.1. Presentation and definition
7.2. Main results/developments
7.3. Asia-Pacific Urinary Catheter Market Value Forecast (USD Million), by Distribution Channel, 2017-2031
7.3.1. Hospital pharmacy
7.3.2. Retail pharmacy
7.3.3. E-commerce
7.4. Asia-Pacific Urinary Catheters Market Attractiveness Analysis, By Distribution Channel

8. Asia Pacific Urinary Catheters Market Analysis and Forecast, by Country/Sub Region
8.1. Main conclusions
8.2. Asia-Pacific Urinary Catheters Market Value Forecast (Million US$), by Country/Sub-Region
8.2.1. Singapore
8.2.2. Australia
8.2.3. South Korea
8.2.4. Japan
8.2.5. Taiwan
8.2.6. China
8.2.7. Rest of Asia Pacific
8.3. Asia-Pacific Urinary Catheters Market Attractiveness Analysis, by Country/Sub-Region

9. Singapore Urinary Catheters Market Analysis and Forecast

10. Australia Urinary Catheters Market Analysis and Forecast

11. South Korea Urinary Catheters Market Analysis and Forecast

12. Japan Urinary Catheters Market Analysis and Forecast

13. Taiwan Urinary Catheters Market Analysis and Forecast

14. China Urinary Catheters Market Analysis and Forecast

15. Rest of Asia Pacific Urinary Catheters Market Analysis and Forecast

16. Competitive landscape
16.1. Company Profiles (2020)
16.1.1. Medtronic
16.1.1.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.1.2. Product portfolio
16.1.1.3. Financial overview
16.1.1.4. Strategic overview
16.1.1.5. SWOT analysis
16.1.2. Advin Health Care
16.1.2.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.2.2. Product portfolio
16.1.2.3. Strategic overview
16.1.2.4. SWOT analysis
16.1.3. B. Braun Melsungen AG
16.1.3.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.3.2. Product portfolio
16.1.3.3. Financial overview
16.1.3.4. Strategic overview
16.1.3.5. SWOT analysis
16.1.4. Medline Industries, Inc.
16.1.4.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.4.2. Product portfolio
16.1.4.3. Strategic overview
16.1.4.4. SWOT analysis
16.1.5. Becton, Dickinson & Company
16.1.5.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.5.2. Product portfolio
16.1.5.3. Financial overview
16.1.5.4. Strategic overview
16.1.5.5. SWOT analysis
16.1.6. Boston Scientific Corporation or its affiliates
16.1.6.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.6.2. Product portfolio
16.1.6.3. Financial overview
16.1.6.4. Strategic overview
16.1.6.5. SWOT analysis
16.1.7. Coloplast Group
16.1.7.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.7.2. Product portfolio
16.1.7.3. Financial overview
16.1.7.4. Strategic overview
16.1.7.5. SWOT analysis
16.1.8. ConvaTec, Inc.
16.1.8.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.8.2. Product portfolio
16.1.8.3. Strategic overview
16.1.8.4. SWOT analysis
16.1.9. Flexicare (Group) Limited
16.1.9.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.9.2. Product portfolio
16.1.9.3. Strategic overview
16.1.9.4. SWOT analysis
16.1.10. Hollister Incorporated
16.1.10.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.10.2. Product portfolio
16.1.10.3. Strategic overview
16.1.10.4. SWOT analysis
16.1.11. Incorporated Teleflex
16.1.11.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.11.2. Product portfolio
16.1.11.3. Financial overview
16.1.11.4. Strategic overview
16.1.11.5. SWOT analysis
16.1.12. Well Lead Medical Co., Ltd.
16.1.12.1. Presentation of the company (headquarters, sectors of activity, strength of employees)
16.1.12.2. Product portfolio
16.1.12.3. Strategic overview
16.1.12.4. SWOT analysis

For more information on this report, visit https://www.researchandmarkets.com/r/tneepn

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Share.

Comments are closed.